Evolutionary Pathways to Persistence of Highly Fit and Resistant Hepatitis C Virus Protease Inhibitor Escape Variants. [electronic resource]
Producer: 20200703Description: 771-787 p. digitalISSN:- 1527-3350
- 2-Naphthylamine
- Aminoisobutyric Acids
- Anilides -- therapeutic use
- Antiviral Agents -- therapeutic use
- Benzimidazoles -- therapeutic use
- Carbamates -- therapeutic use
- Cyclopropanes
- Denmark
- Drug Resistance, Viral -- genetics
- Drug Therapy, Combination
- Female
- Genotype
- Hepacivirus -- drug effects
- Hepatitis C, Chronic -- diagnosis
- Humans
- Lactams, Macrocyclic
- Leucine -- analogs & derivatives
- Male
- Prognosis
- Proline -- analogs & derivatives
- Protease Inhibitors -- pharmacology
- Pyrrolidines
- Quinoxalines -- therapeutic use
- Sulfonamides -- therapeutic use
- Uracil -- analogs & derivatives
- Valine
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
There are no comments on this title.
Log in to your account to post a comment.